Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “immunotherapy”

175 pharma patents match "immunotherapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 175
Index total 30,257
Page 4 / 8

Quick answer

This filtered view shows 175 pharmaceutical patents matching "immunotherapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

175 results for “immunotherapy” · 30,257 patents in full index Clear search

  1. US 11254913

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted
  2. US 11246950

    Combination cancer immunotherapy with pentaaza macrocyclic ring complex

    Galera Labs, LLC · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted
  3. US 11241456

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  4. US 11236139

    Combination immunotherapy

    The United States Government represented by the Department of Veterans Affairs · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  5. US 11213592

    Antibody-sting agonist conjugates and their use in immunotherapy

    The Board of Regents of the University of Texas System · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted
  6. US 11202804

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  7. US 11202803

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  8. US 11168303

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  9. US 11168304

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  10. US 11116838

    Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy

    Inovio Pharmaceuticals, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  11. US 11083752

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  12. US 11059880

    Redirected cells with MHC chimeric receptors and methods of use in immunotherapy

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  13. US 11052116

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  14. US 11052115

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  15. US 11040070

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  16. US 11033635

    Antibody-STING agonist conjugates and their use in immunotherapy

    The Board of Regents of the University of Texas System · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  17. US 11013770

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  18. US 11013803

    Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 25, 2021 · Expires May 20, 2041

    granted
  19. US 11007226

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  20. US 10993967

    Combinatorial cancer immunotherapy

    Senti Biosciences, Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  21. US 10983128

    CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy

    Providence Health & Services · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  22. US 10980868

    VEGFR-2 targeting immunotherapy approach

    Vaximm AG · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  23. CN 112638413

    Oral immunotherapy unit dose dispensing systems and methods

    ALLERGEN RES CORPORATION · Granted Apr 9, 2021 · Expires Apr 4, 2041

    granted
  24. US 10953046

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted